Research Articles
Research articles concerning NAFLD are extracted from PubMed. For each individual article, related therapeutic strategies, targets, drugs and associated diseases in NAFLDkb are presented with knowledge graphs.
stats1
stats2
stats3
stats4
Search for:
Diabetes mellitus4971 records.
| Article ID | PMID | Source | Title | Publish Year | |
|---|---|---|---|---|---|
| A06106 | 33006125 | Adv Ther | Clinical Characteristics of a Non-Alcoholic Fatty Liver Disease Population Across the Fibrosis Spectrum Measured by Magnetic Resonance Elastography: Analysis of Screening Data. | 2020 | Details |
| A06109 | 33004402 | BMJ Open Diabetes Res Care | Metabolic and energetic benefits of microRNA-22 inhibition. | 2020 | Details |
| A06147 | 32987188 | Mol Metab | Glucagon-like peptide-1 receptor co-agonists for treating metabolic disease. | 2020 | Details |
| A06155 | 32984791 | JHEP Rep | Association between remnant lipoprotein cholesterol levels and non-alcoholic fatty liver disease in adolescents. | 2020 | Details |
| A06178 | 32978491 | Sci Rep | FIB-4 index is a marker for a subsequent decrease in insulin secretion in a non-diabetic Japanese population. | 2020 | Details |
| A06190 | 32975679 | Adv Ther | Effect of Empagliflozin on Liver Steatosis and Fibrosis in Patients With Non-Alcoholic Fatty Liver Disease Without Diabetes: A Randomized, Double-Blind, Placebo-Controlled Trial. | 2020 | Details |
| A06195 | 32973925 | Therap Adv Gastroenterol | The role of the gut microbiome and exercise in non-alcoholic fatty liver disease. | 2020 | Details |
| A06203 | 32970896 | Clin Transplant | Association between obesity after liver transplantation and steatosis, inflammation, and fibrosis of the graft. | 2020 | Details |
| A06204 | 32970356 | Liver Int | Impact of metabolic risk factors on the severity and outcome of patients with alcohol-associated acute-on-chronic liver failure. | 2021 | Details |
| A06206 | 32967678 | Lipids Health Dis | Association between sitting time and non-alcoholic fatty live disease in South Korean population: a cross-sectional study. | 2020 | Details |
| A06212 | 32965675 | Hepatology | Activating Adenosine Monophosphate-Activated Protein Kinase Mediates Fibroblast Growth Factor 1 Protection From Nonalcoholic Fatty Liver Disease in Mice. | 2021 | Details |
| A06216 | 32964202 | JHEP Rep | Contribution of sarcopenia and physical inactivity to mortality in people with non-alcoholic fatty liver disease. | 2020 | Details |
| A06217 | 32964201 | JHEP Rep | The Fatty Liver Assessment in Germany (FLAG) cohort study identifies large heterogeneity in NAFLD care. | 2020 | Details |
| A06218 | 32964054 | J Diabetes Res | Association between Thyroid Function and Nonalcoholic Fatty Liver Disease in Euthyroid Type 2 Diabetes Patients. | 2020 | Details |
| A06228 | 32961610 | J Diabetes Investig | Prevalence of non-alcoholic fatty liver disease and factors associated with it in Indian women with a history of gestational diabetes mellitus. | 2020 | Details |
| A06232 | 32961235 | Life Sci | Liraglutide modulates gut microbiome and attenuates nonalcoholic fatty liver in db/db mice. | 2020 | Details |
| A06246 | 32952876 | World J Hepatol | Glucagon-like peptide-1 receptor agonists in non-alcoholic fatty liver disease: An update. | 2020 | Details |
| A06263 | 32947952 | Nutrients | Anti-Diabetic Obesity Effects of Wasabia Japonica Matsum Leaf Extract on 45% Kcal High-Fat Diet-Fed Mice. | 2020 | Details |
| A06264 | 32947869 | Biomolecules | Inflammation in Obesity-Related Complications in Children: The Protective Effect of Diet and Its Potential Role as a Therapeutic Agent. | 2020 | Details |
| A06274 | 32945071 | Diabetes Obes Metab | A look to the future in non-alcoholic fatty liver disease: Are glucagon-like peptide-1 analogues or sodium-glucose co-transporter-2 inhibitors the answer? | 2020 | Details |
| A06291 | 32939691 | Adv Ther | A New, Non-Invasive Scale for Steatosis Developed Using Real-World Data From Russian Outpatients to Aid in the Diagnosis of Non-Alcoholic Fatty Liver Disease. | 2020 | Details |
| A06292 | 32939643 | Biol Trace Elem Res | Zinc Supplementation and Strength Exercise in Rats with Type 2 Diabetes: Akt and PTP1B Phosphorylation in Nonalcoholic Fatty Liver. | 2020 | Details |
| A06293 | 32938692 | Gut | Non-alcoholic fatty liver disease and risk of incident diabetes mellitus: an updated meta-analysis of 501 022 adult individuals. | 2020 | Details |
| A06305 | 32934691 | Exp Ther Med | Abnormal metabolic processes involved in the pathogenesis of non-alcoholic fatty liver disease (Review). | 2020 | Details |
| A06306 | 32934047 | Clin Med (Lond) | Non-alcoholic fatty liver disease. | 2020 | Details |
| A06309 | 32933722 | Tissue Cell | Liraglutide in combination with human umbilical cord mesenchymal stem cell could improve liver lesions by modulating TLR4/NF-kB inflammatory pathway and oxidative stress in T2DM/NAFLD rats. | 2020 | Details |
| A06313 | 32932674 | Molecules | Brown Seaweeds for the Management of Metabolic Syndrome and Associated Diseases. | 2020 | Details |
| A06317 | 32931760 | Am J Med | The Impact of Nonalcoholic Fatty Liver Disease in Primary Care: A Population Health Perspective. | 2020 | Details |
| A06331 | 32925501 | Eur J Gastroenterol Hepatol | Obstructive sleep apnea and severity of nonalcoholic fatty liver disease. | 2021 | Details |
| A06336 | 32924000 | Metabol Open | The incidence of COVID-19 in patients with metabolic syndrome and non-alcoholic steatohepatitis: A population-based study. | 2020 | Details |
| A06360 | 32916379 | Nutrition | Pleiotropic ameliorative effects of ellagitannin geraniin against metabolic syndrome induced by high-fat diet in rats. | 2020 | Details |
| A06367 | 32912770 | Dig Liver Dis | Antidiabetic drugs and non-alcoholic fatty liver disease: A systematic review, meta-analysis and evidence map. | 2020 | Details |
| A06368 | 32910776 | Diabetes Care | Role of Patatin-Like Phospholipase Domain-Containing 3 Gene for Hepatic Lipid Content and Insulin Resistance in Diabetes. | 2020 | Details |
| A06401 | 32892547 | Turk J Med Sci | Exenatide improves cardiovascular risk factors in obese patients with type 2 diabetes mellitus: a prospective study | 2021 | Details |
| A06411 | 32889666 | Rev Endocr Metab Disord | Hypothalamus-pituitary-adrenal Axis in Glucolipid metabolic disorders. | 2020 | Details |
| A06432 | 32882583 | Biomed Pharmacother | An update on β-sitosterol: A potential herbal nutraceutical for diabetic management. | 2020 | Details |
| A06449 | 32878486 | Expert Rev Gastroenterol Hepatol | Current perspectives on the pathophysiology of metabolic associated fatty liver disease: are macrophages a viable target for therapy? | 2020 | Details |
| A06453 | 32877569 | Clin Infect Dis | Increased Body Mass Index and Type 2 Diabetes Are the Main Predictors of Nonalcoholic Fatty Liver Disease and Advanced Fibrosis in Liver Biopsies of Patients With Human Immunodeficiency Virus Monoinfection. | 2021 | Details |
| A06462 | 32871978 | Medicine (Baltimore) | Hepatic fibrosis is associated with total proteinuria in Korean patients with type 2 diabetes. | 2020 | Details |
| A06467 | 32868684 | Curr Opin Clin Nutr Metab Care | Dietary protein intake and obesity-associated cardiometabolic function. | 2020 | Details |
| A06475 | 32865597 | Diabetologia | Effect of dulaglutide on liver fat in patients with type 2 diabetes and NAFLD: randomised controlled trial (D-LIFT trial). | 2020 | Details |
| A06484 | 32862405 | Endocrine | PNPLA3 I148M is involved in the variability in anti-NAFLD response to exenatide. | 2020 | Details |
| A06501 | 32850903 | Front Med (Lausanne) | Insights Into Extracellular Vesicles as Biomarker of NAFLD Pathogenesis. | 2020 | Details |
| A06514 | 32847841 | BMJ Open Diabetes Res Care | Serum levels of mac-2 binding protein are associated with diabetic microangiopathy and macroangiopathy in people with type 2 diabetes. | 2020 | Details |
| A06515 | 32846929 | Nutrients | A Traditional Korean Diet Alters the Expression of Circulating MicroRNAs Linked to Diabetes Mellitus in a Pilot Trial. | 2020 | Details |
| A06519 | 32843301 | Sleep Med | Obstructive sleep apnea, chronic obstructive pulmonary disease and NAFLD: an individual participant data meta-analysis. | 2020 | Details |
| A06520 | 32843283 | J Diabetes Complications | Newer second-line glucose-lowering drugs versus thiazolidinediones on cirrhosis risk among older US adult patients with type 2 diabetes. | 2020 | Details |
| A06521 | 32841652 | J Allergy Clin Immunol | Regulating metabolic inflammation by nutritional modulation. | 2020 | Details |
| A06525 | 32841140 | Medicina (B Aires) | [Diagnosis and treatment of non-alcoholic fatty liver disease. Argentine Association for the Study of Liver Diseases, year 2019]. | 2020 | Details |
| A06530 | 32839076 | Eur J Intern Med | Screening for nonalcoholic fatty liver disease in patients with type 2 diabetes mellitus using transient elastography - a prospective, cross sectional study. | 2020 | Details |
| A06536 | 32833552 | J Med Food | Green Tea Consumption May Be Associated with Cardiovascular Disease Risk and Nonalcoholic Fatty Liver Disease in Type 2 Diabetics: A Cross-Sectional Study in Southeast China. | 2020 | Details |
| A06539 | 32832560 | J Diabetes Res | The Intricate Relationship between Type 2 Diabetes Mellitus (T2DM), Insulin Resistance (IR), and Nonalcoholic Fatty Liver Disease (NAFLD). | 2020 | Details |
| A06542 | 32832491 | Can J Gastroenterol Hepatol | Associations between Phase Angle Values Obtained by Bioelectrical Impedance Analysis and Nonalcoholic Fatty Liver Disease in an Overweight Population. | 2020 | Details |
| A06545 | 32831555 | J Family Community Med | Prevalence and risk factors for nonalcoholic fatty liver disease in obese children in rural Punjab, India. | 2020 | Details |
| A06548 | 32829997 | J Diabetes Complications | NAFLD fibrosis score (NFS) can be used in outpatient services to identify chronic vascular complications besides advanced liver fibrosis in type 2 diabetes. | 2020 | Details |
| A06553 | 32827432 | J Clin Endocrinol Metab | Prevalence of Nonalcoholic Fatty Liver Disease (NAFLD) in Patients With Type 1 Diabetes Mellitus: A Systematic Review and Meta-Analysis. | 2020 | Details |
| A06556 | 32825885 | Indian J Tuberc | An unique case report: Unusual presentation of mediastinal lymph node tuberculosis in an adult. | 2020 | Details |
| A06572 | 32822391 | PLoS One | Clinical spectrum of non-alcoholic fatty liver disease in patients with diabetes mellitus. | 2020 | Details |
| A06580 | 32821336 | World J Hepatol | Non-alcoholic steatohepatitis and the risk of myocardial infarction: A population-based national study. | 2020 | Details |
| A06581 | 32821071 | World J Gastroenterol | Helicobacter pylori infection: Beyond gastric manifestations. | 2020 | Details |
| A06582 | 32821068 | World J Gastroenterol | Clinical considerations in the management of non-alcoholic steatohepatitis cirrhosis pre- and post-transplant: A multi-system challenge. | 2020 | Details |
| A06586 | 32819566 | Biochem Biophys Res Commun | Genetic ablation of Fas-activated serine/threonine kinase ameliorates obesity-related hepatic glucose and lipid metabolic disorders via sirtuin-1 signaling. | 2020 | Details |
| A06587 | 32819262 | Curr Drug Saf | Efficacy and Cardiovascular Safety of DPP-4 Inhibitors. | 2021 | Details |
| A06601 | 32812688 | Pediatr Diabetes | Effects of fatty liver on the size and composition of high-density lipoprotein cholesterol subpopulations in adolescents with type 2 diabetes mellitus. | 2020 | Details |
| A06612 | 32808824 | Can J Physiol Pharmacol | Intricacies of the endothelin system in human obesity: role in the development of complications and potential as a therapeutic target. | 2020 | Details |
| A06613 | 32808114 | J Physiol Biochem | Potential roles of bone morphogenetic protein-9 in glucose and lipid homeostasis. | 2020 | Details |
| A06615 | 32807638 | Nutr Metab Cardiovasc Dis | Genetic susceptibility of increased intestinal permeability is associated with progressive liver disease and diabetes in patients with non-alcoholic fatty liver disease. | 2020 | Details |
| A06624 | 32803141 | Cardiovasc Endocrinol Metab | Nonalcoholic fatty liver disease: implications for endocrinologists and cardiologists. | 2020 | Details |
| A06633 | 32800550 | Biochem Biophys Res Commun | Metformin, resveratrol, and exendin-4 inhibit high phosphate-induced vascular calcification via AMPK-RANKL signaling. | 2020 | Details |
| A06637 | 32798709 | Clin Gastroenterol Hepatol | Effects of Metformin Exposure on Survival in a Large National Cohort of Patients With Diabetes and Cirrhosis. | 2020 | Details |
| A06644 | 32796353 | Eur J Gastroenterol Hepatol | A personalized treatment program in persons with type 2 diabetes is associated with a reduction in liver steatosis. | 2021 | Details |
| A06652 | 32793612 | Front Med (Lausanne) | FIB-4 Regression With Direct-Acting Antiviral Therapy in Patients With Hepatitis C Infection: A Safety-Net Hospital Experience. | 2020 | Details |
| A06658 | 32791578 | Clin Mol Hepatol | Beneficial effect of anti-diabetic drugs for nonalcoholic fatty liver disease. | 2020 | Details |
| A06660 | 32791310 | Diabetes Metab | Trimethylamine N-oxide levels are associated with NASH in obese subjects with type 2 diabetes. | 2020 | Details |
| A06675 | 32785012 | Int J Mol Sci | Glucagon-Like Peptide-1 Receptor Agonist Prevented the Progression of Hepatocellular Carcinoma in a Mouse Model of Nonalcoholic Steatohepatitis. | 2020 | Details |
| A06676 | 32784205 | BMJ Open Gastroenterol | Association of non-alcoholic fatty liver disease and polycystic ovarian syndrome. | 2020 | Details |
| A06680 | 32782883 | Cureus | An Observational Study of Reduction in Glycemic Parameters and Liver Stiffness by Saroglitazar 4 mg in Patients With Type 2 Diabetes Mellitus and Nonalcoholic Fatty Liver Disease. | 2020 | Details |
| A06687 | 32780624 | Metab Syndr Relat Disord | Lumican in Obese Patients with Nonalcoholic Fatty Liver Disease With or Without Prediabetes. | 2020 | Details |
| A06690 | 32779505 | J Am Heart Assoc | Effects of Epeleuton, a Novel Synthetic Second-Generation n-3 Fatty Acid, on Non-Alcoholic Fatty Liver Disease, Triglycerides, Glycemic Control, and Cardiometabolic and Inflammatory Markers. | 2020 | Details |
| A06699 | 32775976 | JHEP Rep | Cost of non-alcoholic steatohepatitis in Europe and the USA: The GAIN study. | 2020 | Details |
| A06700 | 32775974 | JHEP Rep | Volatomic analysis identifies compounds that can stratify non-alcoholic fatty liver disease. | 2020 | Details |
| A06714 | 32772844 | Trop Doct | Non-alcoholic fatty liver disease in patients with hypothyroidism presenting at a rural tertiary care centre in north India. | 2020 | Details |
| A06721 | 32769900 | Medicine (Baltimore) | Hypoglycemic agents for non-alcoholic fatty liver disease with type 2 diabetes mellitus: A protocol for systematic review and network meta-analysis. | 2020 | Details |
| A06735 | 32765720 | Exp Ther Med | Non-alcoholic fatty liver disease: A major challenge in type 2 diabetes mellitus (Review). | 2020 | Details |
| A06746 | 32762728 | BMC Pharmacol Toxicol | Pharmacokinetic and metabolomic analyses of Mangiferin calcium salt in rat models of type 2 diabetes and non-alcoholic fatty liver disease. | 2020 | Details |
| A06755 | 32759166 | BMJ Open Diabetes Res Care | Association between non-alcoholic fatty liver disease-associated hepatic fibrosis and bone mineral density in postmenopausal women with type 2 diabetes or impaired glucose regulation. | 2020 | Details |
| A06767 | 32754976 | Mol Nutr Food Res | Metabolic Inflammation in Obesity-At the Crossroads between Fatty Acid and Cholesterol Metabolism. | 2020 | Details |
| A06772 | 32752277 | Int J Mol Sci | Iron Metabolism in Obesity and Metabolic Syndrome. | 2020 | Details |
| A06777 | 32751658 | Cells | The Inflammasome in Chronic Complications of Diabetes and Related Metabolic Disorders. | 2020 | Details |
| A06787 | 32745698 | Diabetes Res Clin Pract | Screening strategies for nonalcoholic fatty liver disease in type 2 diabetes: Insights from NHANES 2005-2016. | 2020 | Details |
| A06794 | 32742574 | World J Hepatol | Non-alcoholic fatty liver disease is not independent risk factor for cardiovascular disease event: A cohort study. | 2020 | Details |
| A06798 | 32742124 | World J Gastroenterol | Management of nonalcoholic fatty liver disease in the Middle East. | 2020 | Details |
| A06804 | 32738842 | J Assoc Physicians India | Study and Comparison of Metabolic Profile of Lean and Obese Subjects with Non Alcoholic Fatty Liver Disease. | 2020 | Details |
| A06837 | 32729704 | Minerva Med | Ancient wheats: beneficial effects on insulin resistance. | 2020 | Details |
| A06842 | 32727275 | Biodemography Soc Biol | Obesity and metabolic outcomes in a safety-net health system. | 2020 | Details |
| A06845 | 32725485 | Diabetes Ther | Establishment of a Risk Prediction Model for Non-alcoholic Fatty Liver Disease in Type 2 Diabetes. | 2020 | Details |
| A06847 | 32725157 | J Clin Endocrinol Metab | Pancreatic Steatosis Associates With Impaired Insulin Secretion in Genetically Predisposed Individuals. | 2020 | Details |
| A06856 | 32720602 | Curr Vasc Pharmacol | Have We Learnt all from IMPROVE-IT? Part I. Core Results and Subanalyses on the Effects of Ezetimibe Added to Statin Therapy Related to Age, Gender and Selected Chronic Diseases (Kidney Disease, Diabetes Mellitus and Non-Alcoholic Fatty Liver Disease). | 2021 | Details |
| A06879 | 32712103 | Gastroenterology | Progression of Fatty Liver Disease in Children Receiving Standard of Care Lifestyle Advice. | 2020 | Details |
| A06886 | 32710190 | Diabetologia | Multi-layered epigenetic regulation of IRS2 expression in the liver of obese individuals with type 2 diabetes. | 2020 | Details |